Diagnosis and treatment of sepsis. The S-2 guidelines of the German Sepsis Society (DSG) and the German Interdisciplinary Association of Critical Care Medicine (DIVI): Part 1;Diagnose und therapie der sepsis: S-2 leitlinien der Deutschen Sepsis-Gesellschaft e. V. (DSG) und der Deutschen Interdisziplinären Vereinigung für Intensiv- und notfallmedizin (DIVI): Teil 1

Intensivmedizin und Notfallmedizin

Volumn 43, Issue 5, 2006, Pages 369-384

  Reinhart, K ^a   Brunkhorst, F M ^a   Bone, H G ^b   Gerlach, H ^c   Grundling M ^d   Kreymann, G ^e   Kujath, P ^f   Marggraf, G ^g   Mayer, K ^h   Meier Hellmann, A ⁱ   Peckelsen, C ^j   Putensen, C ^k   Stuber F ^k   Quintel, M ^l   Ragaller, M ^m   Rossaint, R ⁿ   Weiler, N ^f   Welte, T ^o   Werdan, K ^p  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^c VIVANTES KLINIKUM NEUKÖLLN   (Germany)

^d UNIVERSITY OF GREIFSWALD   (Germany)

^e UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^f UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^g UNIVERSITY HOSPITAL ESSEN   (Germany)

^h JUSTUS LIEBIG UNIVERSITY   (Germany)

ⁱ HELIOS KLINIKUM ERFURT   (Germany)

^j Munich Municipal Hospital   (Germany)

^k UNIVERSITY OF BONN   (Germany)

^l UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^m UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

ⁿ UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^o HANNOVER MEDICAL SCHOOL   (Germany)

^p MARTIN LUTHER UNIVERSITÄT HALLE WITTENBERG   (Germany)

more..

Author keywords

Diagnosis; Germany; Guidelines; Sepsis; Treatment

Indexed keywords

ANTIBIOTIC AGENT; ANTIFUNGAL AGENT;

BLOOD CULTURE; DISEASE SEVERITY; GERMANY; HUMAN; INSULIN TREATMENT; INTERDISCIPLINARY EDUCATION; INTERNATIONAL COOPERATION; MEDICAL SOCIETY; PRACTICE GUIDELINE; REVIEW; SEPSIS; SEPTIC SHOCK; VENTILATOR ASSOCIATED PNEUMONIA;

EID: 33745634411     PISSN: 01753851     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00390-006-0700-7     Document Type: Review

References (301)

1. Yusuf S, Teo K, Woods K (1993) Intravenous magnesium in acute myocardial infarction. An effective, safe, simple, and inexpensive intervention. Circulation 87(6):2043-2046
2. ISIS-4 (1995) A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group. Lancet 345(8951):669-685
3. Sackett DL (1989) Rules of evidence and clinical recommendations on the use of antithrombotic agents. Chest 95(2 Suppl):S2-S4
4. Martin GS, Mannino DM, Eaton S, Moss M (2003) The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 348(16):1546-1554
5. Bates DW, Cook EF, Goldman L, Lee TH (1990) Predicting bacteremia in hospitalized patients. A prospectively validated model. Ann Intern Med 113(7):495-500
6. Bates DW, Sands K, Miller E et al (1997) Predicting bacteremia in patients with sepsis syndrome. Academic Medical Center Consortium Sepsis Project Working Group. J Infect Dis 176(6):1538-1551
7. Crowe M, Ispahani P, Humphreys H, Kelley T, Winter R (1998) Bacteraemia in the adult intensive care unit of a teaching hospital in Nottingham, UK, 1985-1996. Eur J Clin Microbiol Infect Dis 17(6):377-384
8. Leibovici L, Greenshtain S, Cohen O, Mor F, Wysenbeek AJ (1991) Bacteremia in febrile patients. A clinical model for diagnosis. Arch Intern Med 151(9):1801-1806
9. Alberti C, Brun-Buisson C, Burchardi H et al (2002) Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study. Intensive Care Med 28(2):108-121
10. Vincent JL, Bihari DJ, Suter PM et al (1995) The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. Jama 274 (8):639-644
11. ACCP/SCCM Consensus Conference Committee (1992) Definition for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20(6):864-874
12. Zeni F, Freeman B, Natanson C (1997) Anti-inflammatory therapies to treat sepsis and septic shock: a reassessment. Crit Care Med 25(7):1095-1100
13. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM (1996) CDC definitions for nosocomial infections. In: Olmsted RN (ed) PIC Infection Control and Applied Epidemiology: Principles and Practice. Mosby, St. Louis, pp A1-A20
14. Harbarth S, Holeckova K, Froidevaux C et al (2001) Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med 164(3):396-402
15. Müller B, Becker KL, Schächinger H et al (2000) Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit. Crit Care Med 28(4):977-983
16. Brunkhorst FM, Wegscheider K, Forycki ZF, Brunkhorst R (2000) Procalcitonin for early diagnosis and differentiation of SIRS, sepsis, severe sepsis, and septic shock. Intensive Care Med 26(Suppl 2):S148-S152
17. Clec'h C, Ferriere F, Karoubi P et al (2004) Diagnostic and prognostic value of procalcitonin in patients with septic shock. Crit Care Med 32(5):1166-1169
18. Meisner M, Tschaikowsky K, Hutzler A, Schick C, Schuttler J (1998) Postoperative plasma concentrations of procalcitonin after different types of surgery. Intensive Care Med 24(7):680-684
19. Gramm HJ, Hannemann L, Reinhart K, Lode H (1995) Sepsis: ein Begriff im Wandel. Möglichkeiten und Grenzen der Diagnose anhand klinischer Kriterien. Dtsch Med Wochenschr 120(14):498-502
20. Smith-Elekes S, Weinstein MP (1993) Blood cultures. Infect Dis Clin North Am 7(2):221-234
21. Reimer LG, Wilson ML, Weinstein MP (1997) Update on detection of bacteremia and fungemia. Clin Microbiol Rev 10(3):444-465
22. Shafazand S, Weinacker AB (2002) Blood cultures in the critical care unit: improving utilization and yield. Chest 122(5):1727-1736
23. Darby JM, Linden P, Pasculle W, Saul M (1997) Utilization and diagnostic yield of blood cultures in a surgical intensive care unit. Crit Care Med 25(6):989-994
24. Shahar E, Wohl-Gottesman BS, Shenkman L (1990) Contamination of blood cultures during venepuncture: fact or myth? Postgrad Med J 66(782):1053-1058
25. Souvenir D, Anderson DE Jr, Palpant S et al (1998) Blood cultures positive for coagulase-negative staphylococci: antisepsis, pseudobacteremia, and therapy of patients. J Clin Microbiol 36(7):1923-1926
26. Martinez JA, DesJardin JA, Aronoff M, Supran S, Nasraway SA, Snydman DR (2002) Clinical utility of blood cultures drawn from central venous or arterial catheters in critically ill surgical patients. Crit Care Med 30(1):7-13
27. Wilson ML (1996) General principles of specimen collection and transport. Clin Infect Dis 22(5):766-777
28. Spitalnic SJ, Woolard RH, Mermel LA (1995) The significance of changing needles when inoculating blood cultures: a meta-analysis. Clin Infect Dis 21(5):1103-1106
29. Weinstein MP, Towns ML, Quartey SM et al (1997) The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults. Clin Infect Dis 24(4):584-602
30. Washington JA, 2nd (1975) Blood cultures: principles and techniques. Mayo Clin Proc 50(2):91-98
31. Li J, Plorde JJ, Carlson LG (1994) Effects of volume and periodicity on blood cultures. J Clin Microbiol 32(11):2829-2831
32. Wunderink RG (2000) Clinical criteria in the diagnosis of ventilator-associated pneumonia. Chest 117(4 Suppl 2):S191-S194
33. Singh N, Rogers P, Atwood CW, Wagener MM, Yu VL (2000) Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription. Am J Respir Crit Care Med 162(2 Pt 1):505-511
34. Fartoukh M, Maitre B, Honore S, Cerf C, Zahar JR, Brun-Buisson C (2003) Diagnosing pneumonia during mechanical ventilation: the clinical pulmonary infection score revisited. Am J Respir Crit Care Med 168(2):173-179
35. Michel F, Franceschini B, Berger P et al (2005) Early antibiotic treatment for BAL-confirmed ventilator-associated pneumonia: a role for routine endotracheal aspirate cultures. Chest 127(2):589-597
36. Luyt CE, Chastre J, Fagon JY (2004) Value of the clinical pulmonary infection score for the identification and management of ventilator-associated pneumonia. Intensive Care Med 30(5):844-852
37. Torres A, El-Ebiary M (2000) Bronchoscopic BAL in the diagnosis of ventilator-associated pneumonia. Chest 117(4 Suppl 2):S198-S202
38. Cook D, Mandell L (2000) Endotracheal aspiration in the diagnosis of ventilator-associated pneumonia. Chest 117(4 Suppl 2):S195-S197
39. Mauch H, Wagner J (1999) MIQ - Qualitätsstandards in der mikrobiologisch-infektiologischen Diagnostik. Heft 7: Infektionen der tiefen Atemwege, Teil 1. Urban & Fischer
40. Gerbeaux P, Ledoray V, Boussuges A, Molenat F, Jean P, Sainty JM (1998) Diagnosis of nosocomial pneumonia in mechanically ventilated patients: repeatability of the bronchoalveolar lavage. Am J Respir Crit Care Med 157(1):76-80
41. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia (2005) Am J Respir Crit Care Med 171(4):388-416
42. Llewelyn M, Cohen J (2001) Diagnosis of infection in sepsis. Intensive Care Med 27(Suppl 1):S10-S32
43. Carratala J, Gudiol F, Pallares R et al (1994) Risk factors for nosocomial Legionella pneumophila pneumonia. Am J Respir Crit Care Med 149(3 Pt 1):625-629
44. Dobbins BM, Kite P, Wilcox MH (1999) Diagnosis of central venous catheter related sepsis - a critical look inside. J Clin Pathol 52(3):165-172
45. Sherertz RJ (1996) Surveillance for infections associated with vascular catheters. Infect Control Hosp Epidemiol 17(11):746-752
46. Blot F, Nitenberg G, Chachaty E et al (1999) Diagnosis of catheter-related bacteraemia: a prospective comparison of the time to positivity of hub-blood versus peripheral-blood cultures. Lancet 354(9184):1071-1077
47. Tanguy M, Seguin P, Laviolle B, Desbordes L, Malledant Y (2005) Hub qualitative blood culture is useful for diagnosis of catheter-related infections in critically ill patients. Intensive Care Med 31(5):645-648
48. Catton JA, Dobbins BM, Kite P et al (2005) In situ diagnosis of intravascular catheter-related bloodstream infection: a comparison of quantitative culture, differential time to positivity, and endoluminal brushing. Crit Care Med 33(4):787-791
49. Raad, II, Baba M, Bodey GP (1995) Diagnosis of catheter-related infections: the role of surveillance and targeted quantitative skin cultures. Clin Infect Dis 20(3):593-597
50. Cobb DK, High KP, Sawyer RG et al (1992) A controlled trial of scheduled replacement of central venous and pulmonary-artery catheters. N Engl J Med 327(15):1062-1068
51. Cook D, Randolph A, Kernerman P et al (1997) Central venous catheter replacement strategies: a systematic review of the literature. Crit Care Med 25(8):1417-1424
52. Eyer S, Brummitt C, Crossley K, Siegel R, Cerra F (1990) Catheter-related sepsis: prospective, randomized study of three methods of long-term catheter maintenance. Crit Care Med 18(10):1073-1079
53. Brook I, Frazier EH (1998) Aerobic and anaerobic microbiology of retroperitoneal abscesses. Clin Infect Dis 26(4):938-941
54. Nichols RL, Smith JW (1993) Wound and intraabdominal infections: microbiological considerations and approaches to treatment. Clin Infect Dis 16(Suppl 4):S266-S272
55. Brook I, Frazier EH (1999) Microbiology of subphrenic abscesses: a 14-year experience. Am Surg 65(11):1049-1053
56. Marshall JC, Innes M (2003) Intensive care unit management of intra-abdominal infection. Crit Care Med 31(8):2228-2237
57. Büchner T, Fegeler W, Bernhardt H et al (2002) Treatment of severe Candida infections in high-risk patients in Germany: consensus formed by a panel of interdisciplinary investigators. Eur J Clin Microbiol Infect Dis 21(5):337-52
58. Blumberg HM, Jarvis WR, Soucie JM et al (2001) Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. The National Epidemiology of Mycosis Survey. Clin Infect Dis 33(2):177-186
59. Petri MG, Konig J, Moecke HP et al (1997) Epidemiology of invasive mycosis in ICU patients: a prospective multicenter study in 435 non-neutropenic patients. Paul-Ehrlich Society for Chemotherapy, Divisions of Mycology and Pneumonia Research. Intensive Care Med 23(3):317-325
60. Pappas PG, Rex JH, Sobel JD et al (2004) Guidelines for treatment of candidiasis. Clin Infect Dis 38(2):161-189
61. Richards M, Thursky K, Buising K (2003) Epidemiology, Prevalence, and Sites of Infections in Intensive Care Units. Semin Respir Crit Care Med 24(1):3-22
62. Brooks K, Whitten S, Quigley D (1998) Reducing the incidence of ventilator-related pneumonia. J Healthc Qual 20(1):14-19
63. Kaye J, Ashline V, Erickson D et al (2000) Critical care bug team: a multidisciplinary team approach to reducing ventilator-associated pneumonia. Am J Infect Control 28(2):197-201
64. Kelleghan SI, Salemi C, Padilla S et al (1993) An effective continuous quality improvement approach to the prevention of ventilator-associated pneumonia. Am J Infect Control 21(6):322-330
65. Joiner GA, Salisbury D, Bollin GE (1996) Utilizing quality assurance as a tool for reducing the risk of nosocomial ventilator-associated pneumonia. Am J Med Qual 11(2):100-103
66. Nicotra D, Ulrich C (1996) Process improvement plan for the reduction of nosocomial pneumonia in patients on ventilators. J Nurs Care Qual 10(4):18-23
67. Zack JE, Garrison T, Trovillion E et al (2002) Effect of an education program aimed at reducing the occurrence of ventilator-associated pneumonia. Crit Care Med 30(11):2407-2412
68. Salahuddin N, Zafar A, Sukhyani L et al (2004) Reducing ventilator-associated pneumonia rates through a staff education programme. J Hosp Infect 57 (3):223-227
69. Brook AD, Ahrens TS, Schaiff R et al (1999) Effect of a nursing-implemented sedation protocol on the duration of mechanical ventilation. Crit Care Med 27(12):2609-2615
70. Kollef MH, Shapiro SD, Silver P et al (1997) A randomized, controlled trial of protocol-directed versus physician-directed weaning from mechanical ventilation. Crit Care Med 25(4):567-574
71. Perren A, Domenighetti G, Mauri S, Genini F, Vizzardi N (2002) Protocol-directed weaning from mechanical ventilation: clinical outcome in patients randomized for a 30-min or 120-min trial with pressure support ventilation. Intensive Care Med 28(8):1058-1063
72. Haley RW, Culver DH, White JW et al (1985) The efficacy of infection surveillance and control programs in preventing nosocomial infections in US hospitals. Am J Epidemiol 121(2):182-205
73. Haley RW, Morgan WM, Culver DH et al (1985) Update from the SENIC project. Hospital infection control: recent progress and opportunities under prospective payment. Am J Infect Control 13(3):97-108
74. Horan TC, White JW et al (1986) Nosocomial Infection Surveillance, 1984. MMWR 35(SS-1):17-29
75. CDC (2003) NNIS criteria for determining nosocomial pneumonia. US Department of Health and Human Services, CDC. Atlanta GA
76. Schulze MC, Gastmeier P, Geffers C, Rüden H (2002) Handbuch für die Surveillance von nosokomialen Infektionen nach den Methoden des Krankenhaus-Infektions-Surveillance-Systems KISS: Nomos Verlagsgesellschaft mbH & Co. KG
77. Gaynes RP, Solomon S (1996) Improving hospital-acquired infection rates: the CDC experience. Jt Comm J Qual Improv 22(7):457-467
78. Josephson A, Karanfil L, Alonso H, Watson A, Blight J (1991) Risk-specific nosocomial infection rates. Am J Med 91(3B):S131-S137
79. Drakulovic MB, Torres A, Bauer TT, Nicolas JM, Nogue S, Ferrer M (1999) Supine body position as a risk factor for nosocomial pneumonia in mechanically ventilated patients: a randomised trial. Lancet 354(9193):1851-1858
80. Orozco-Levi M, Torres A, Ferrer M et al (1995) Semirecumbent position protects from pulmonary aspiration but not completely from gastroesophageal reflux in mechanically ventilated patients. Am J Respir Crit Care Med 152(4 Pt 1):1387-1390
81. Torres A, Serra-Batlles J, Ros E et al (1992) Pulmonary aspiration of gastric contents in patients receiving mechanical ventilation: the effect of body position. Ann Intern Med 116(7):540-543
82. Lewis SJ, Egger M, Sylvester PA, Thomas S (2001) Early enteral feeding versus "nil by mouth" after gastrointestinal surgery: systematic review and meta-analysis of controlled trials. BMJ 323(7316):773-776
83. Heyland DK, Novak F, Drover JW, Jain M, Su X, Suchner U (2001) Should immunonutrition become routine in critically ill patients? A systematic review of the evidence. JAMA 286(8):944-953
84. Heys SD, Walker LG, Smith I, Eremin O (1999) Enteral nutritional supplementation with key nutrients in patients with critical illness and cancer: a meta-analysis of randomized controlled clinical trials. Ann Surg 229(4):467-477
85. van den Berghe G, Wouters P, Weekers F et al (2001) Intensive insulin therapy in the critically ill patients. N Engl J Med 345(19):1359-1367
86. Krinsley JS (2004) Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clin Proc 79(8):992-1000
87. Abele-Horn M, Dauber A, Bauernfeind A et al (1997) Decrease in nosocomial pneumonia in ventilated patients by selective oropharyngeal decontamination (SOD). Intensive Care Med 23(2):187-195
88. D'Amico R, Pifferi S, Leonetti C, Torri V, Tinazzi A, Liberati A (1998) Effectiveness of antibiotic prophylaxis in critically ill adult patients: systematic review of randomised controlled trials. Bmj 316 (7140):1275-1285
89. Langlois-Karaga A, Bues-Charbit M, Davignon A et al (1995) Selective digestive decontamination in multiple trauma patients: cost and efficacy. Pharm World Sci 17(1):12-16
90. Nathens AB, Marshall JC (1999) Selective decontamination of the digestive tract in surgical patients: a systematic review of the evidence. Arch Surg 134(2):170-176
91. Quinio B, Albanese J, Bues-Charbit M, Viviand X, Martin C (1996) Selective decontamination of the digestive tract in multiple trauma patients. A prospective double-blind, randomized, placebo-controlled study. Chest 109(3):765-772
92. Stoutenbeek CP, van Saene HK, Miranda DR, Zandstra DF (1984) The effect of selective decontamination of the digestive tract on colonisation and infection rate in multiple trauma patients. Intensive Care Med 10(4):185-192
93. Unertl K, Ruckdeschel G, Selbmann HK et al (1987) Prevention of colonization and respiratory infections in long-term ventilated patients by local antimicrobial prophylaxis. Intensive Care Med 13(2):106-113
94. Kerver AJ, Rommes JH, Mevissen-Verhage EA et al (1988) Prevention of colonization and infection in critically ill patients: a prospective randomized study. Crit Care Med 16(11):1087-1093
95. Ledingham IM, Alcock SR, Eastaway AT, McDonald JC, McKay IC, Ramsay G (1988) Triple regimen of selective decontamination of the digestive tract, systemic cefotaxime, and microbiological surveillance for prevention of acquired infection in intensive care. Lancet 1(8589):785-790
96. Brun-Buisson C, Legrand P, Rauss A et al (1989) Intestinal decontamination for control of nosocomial multi-resistant gram-negative bacilli. Study of an outbreak in an intensive care unit. Ann Intern Med 110 (11):873-881
97. Ulrich C, Harinck-de Weerd JE, Bakker NC, Jacz K, Doornbos L, de Ridder VA (1989) Selective decontamination of the digestive tract with norfloxacin in the prevention of ICU-acquired infections: a prospective randomized study. Intensive Care Med 15(7):424-431
98. Godard J, Guillaume C, Reverdy ME et al (1990) Intestinal decontamination in a polyvalent ICU. A double-blind study. Intensive Care Med 16(5):307-311
99. McClelland P, Murray AE, Williams PS et al (1990) Reducing sepsis in severe combined acute renal and respiratory failure by selective decontamination of the digestive tract. Crit Care Med 18 (9):935-939
100. Rodriguez-Roldan JM, Altuna-Cuesta A, Lopez A et al (1990) Prevention of nosocomial lung infection in ventilated patients: use of an antimicrobial pharyngeal nonabsorbable paste. Crit Care Med 18(11):1239-1242
101. Tetteroo GW, Wagenvoort JH, Castelein A, Tilanus HW, Ince C, Bruining HA (1990) Selective decontamination to reduce gram-negative colonisation and infections after oesophageal resection. Lancet 335(8691):704-707
102. Aerdts SJ, van Dalen R, Clasener HA, Festen J, van Lier HJ, Vollaard EJ (1991) Antibiotic prophylaxis of respiratory tract infection in mechanically ventilated patients. A prospective, blinded, randomized trial of the effect of a novel regimen. Chest 100(3):783-791
103. Blair P, Rowlands BJ, Lowry K, Webb H, Armstrong P, Smilie J (1991) Selective decontamination of the digestive tract: a stratified, randomized, prospective study in a mixed intensive care unit. Surgery 110(2):303-309; discussion 9-10
104. Fox MA, Peterson S, Fabri BM, van Saene HK (1991) Selective decontamination of the digestive tract in cardiac surgical patients. Crit Care Med 19(12):1486-1490
105. Hartenauer U, Thulig B, Diemer W et al (1991) Effect of selective flora suppression on colonization, infection, and mortality in critically ill patients: a one-year, prospective consecutive study. Crit Care Med 19(4):463-473
106. Pugin J, Auckenthaler R, Lew DP, Suter PM (1991) Oropharyngeal decontamination decreases incidence of ventilator-associated pneumonia. A randomized, placebo-controlled, double-blind clinical trial. JAMA 265(20):2704-2710
107. Vandenbroucke-Grauls CM, Vandenbroucke JP (1991) Effect of selective decontamination of the digestive tract on respiratory tract infections and mortality in the intensive care unit. Lancet 338(8771):859-862
108. Cockerill FR, 3rd, Muller SR, Anhalt JP et al (1992) Prevention of infection in critically ill patients by selective decontamination of the digestive tract. Ann Intern Med 117(7):545-553
109. Gastinne H, Wolff M, Delatour F, Faurisson F, Chevret S (1992) A controlled trial in intensive care units of selective decontamination of the digestive tract with nonabsorbable antibiotics. The French Study Group on Selective Decontamination of the Digestive Tract. N Engl J Med 326(9):594-599
110. Hammond JM, Potgieter PD, Saunders GL, Forder AA (1992) Double-blind study of selective decontamination of the digestive tract in intensive care. Lancet 340(8810):5-9
111. Rocha LA, Martin MJ, Pita S et al (1992) Prevention of nosocomial infection in critically ill patients by selective decontamination of the digestive tract. A randomized, double blind, placebo-controlled study. Intensive Care Med 18(7):398-404
112. Winter R, Humphreys H, Pick A, MacGowan AP, Willatts SM, Speller DC (1992) A controlled trial of selective decontamination of the digestive tract in intensive care and its effect on nosocomial infection. J Antimicrob Chemother 30(1):73-87
113. Korinek AM, Laisne MJ, Nicolas MH, Raskine L, Deroin V, Sanson-Lepors MJ (1993) Selective decontamination of the digestive tract in neurosurgical intensive care unit patients: a double-blind, randomized, placebo-controlled study. Crit Care Med 21(10):1466-1473
114. Meta-analysis of randomised controlled trials of selective decontamination of the digestive tract (1993) Selective Decontamination of the Digestive Tract Trialists' Collaborative Group. Bmj 307(6903):S525-S532
115. Ferrer M, Torres A, Gonzalez J et al (1994) Utility of selective digestive decontamination in mechanically ventilated patients. Ann Intern Med 120(5):389-395
116. Nau R, Ruchel R, Mergerian H, Wegener U, Winkelmann T, Prange HW (1990) Emergence of antibiotic-resistant bacteria during selective decontamination of the digestive tract. J Antimicrob Chemother 25(5):881-883
117. Sanchez Garcia M, Cambronero Galache JA, Lopez Diaz J et al (1998) Effectiveness and cost of selective decontamination of the digestive tract in critically ill intubated patients. A randomized, double-blind, placebo-controlled, multicenter trial. Am J Respir Crit Care Med 158(3):908-916
118. Krueger WA, Lenhart FP, Neeser G et al (2002) Influence of combined intravenous and topical antibiotic prophylaxis on the incidence of infections, organ dysfunctions, and mortality in critically ill surgical patients: a prospective, stratified, randomized, double-blind, placebo-controlled clinical trial. Am J Respir Crit Care Med 166(8):1029-1037
119. de Jonge E, Schultz MJ, Spanjaard L et al (2003) Effects of selective decontamination of digestive tract on mortality and acquisition of resistant bacteria in intensive care: a randomised controlled trial. Lancet 362(9389):1011-1016
120. Piarroux R, Grenouillet F, Balvay P et al (2004) Assessment of preemptive treatment to prevent severe candidiasis in critically ill surgical patients. Crit Care Med 32 (12):2443-2449
121. Buchler MW, Baer HU, Brugger LE, Feodorovici MA, Uhl W, Seiler C (1997) Chirurgische Therapie der diffusen Peritonitis: Herdsanierung und intraoperative extensive Lavage. Chirurg 68(8):811-815
122. Kaiser RE, Cerra FB (1981) Progressive necrotizing surgical infections - a unified approach. J Trauma 21(5):349-355
123. Freid MA, Vosti KL (1968) The importance of underlying disease in patients with gram-negative bacteremia. Arch Intern Med 121(5):418-423
124. McCabe WR, Jackson GG (1962) Gram negative bacteremia. Arch Intern Med 110:92-100
125. Bryant RE, Hood AF, Hood CE, Koenig MG (1971) Factors affecting mortality of gram-negative rod bacteremia. Arch Intern Med 127(1):120-128
126. Young LS, Martin WJ, Meyer RD, Weinstein RJ, Anderson ET (1977) Gram-negative rod bacteremia: microbiologic, immunologic, and therapeutic considerations. Ann Intern Med 86(4):456-471
127. Kreger BE, Craven DE, McCabe WR (1980) Gram-negative bacteremia. IV. Re-evaluation of clinical features and treatment in 612 patients. Am J Med 68(3):344-355
128. Leibovici L, Paul M, Poznanski O et al (1997) Monotherapy versus beta-lactam-aminoglycoside combination treatment for gram-negative bacteremia: a prospective, observational study. Antimicrob Agents Chemother 41(5):1127-1133
129. Chow JW, Fine MJ, Shlaes DM et al (1991) Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy. Ann Intern Med 115(8):585-590
130. Vidal F, Mensa J, Almela M et al (1996) Epidemiology and outcome of Pseudomonas aeruginosa bacteremia, with special emphasis on the influence of antibiotic treatment. Analysis of 189 episodes. Arch Intern Med 156(18):2121-2126
131. Schiappa DA, Hayden MK, Matushek MG et al (1996) Ceftazidime-resistant Klebsiella pneumoniae and Escherichia coli bloodstream infection: a case-control and molecular epidemiologic investigation. J Infect Dis 174(3):529-536
132. Caballero-Granado FJ, Cisneros JM, Luque R et al (1998) Comparative study of bacteremias caused by Enterococcus spp. with and without high-level resistance to gentamicin. The Grupo Andaluz para el estudio de las Enfermedades Infecciosas. J Clin Microbiol 36(2):520-525
133. Ispahani P, Pearson NJ, Greenwood D (1987) An analysis of community and hospital-acquired bacteraemia in a large teaching hospital in the United Kingdom. Q J Med 63(241):427-440
134. Leibovici L, Drucker M, Konigsberger H et al (1997) Septic shock in bacteremic patients: risk factors, features and prognosis. Scand J Infect Dis 29(1):71-75
135. Leibovici L, Shraga I, Drucker M, Konigsberger H, Samra Z, Pitlik SD (1998) The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection. J Intern Med 244(5):379-386
136. Kollef MH, Sherman G, Ward S, Fraser VJ (1999) Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest 115(2):462-474
137. Ibrahim EH, Sherman G, Ward S, Fraser VJ, Kollef MH (2000) The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 118(1):146-155
138. Harbarth S, Ferriere K, Hugonnet S, Ricou B, Suter P, Pittet D (2002) Epidemiology and prognostic determinants of bloodstream infections in surgical intensive care. Arch Surg 137(12):1353-1359, discussion 9
139. Hanon FX, Monnet DL, Sorensen TL, Molbak K, Pedersen G, Schonheyder H (2002) Survival of patients with bacteraemia in relation to initial empirical antimicrobial treatment. Scand J Infect Dis 34 (7):520-528
140. Harbarth S, Garbino J, Pugin J, Romand JA, Lew D, Pittet D (2003) Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis. Am J Med 115(7):529-535
141. Zaragoza R, Artero A, Camarena JJ, Sancho S, Gonzalez R, Nogueira JM (2003) The influence of inadequate empirical antimicrobial treatment on patients with bloodstream infections in an intensive care unit. Clin Microbiol Infect 9(5):412-418
142. Leone M, Bourgoin A, Cambon S, Dubuc M, Albanese J, Martin C (2003) Empirical antimicrobial therapy of septic shock patients: adequacy and impact on the outcome. Crit Care Med 31(2):462-467
143. Garnacho-Montero J, Garcia-Garmendia JL, Barrero-Almodovar A, Jimenez-Jimenez FJ, Perez-Paredes C, Ortiz-Leyba C (2003) Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis. Crit Care Med 31(12):2742-2751
144. Dellinger RP, Carlet J, Masur H et al (2004) Surviving Sepsis Campaign for management of severe sepsis and septic shock. Crit Care Med 32:858-872
145. Paul M, Benuri-Silbiger I, Soares-Weiser K, Leibovici L (2004) Beta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: systematic review and meta-analysis of randomised trials. BMJ 328(7441):668
146. Byl B, Jacobs F, Wallemacq P et al (2003) Vancomycin penetration of uninfected pleural fluid exudate after continuous or intermittent infusion. Antimicrob Agents Chemother 47(6):2015-2017
147. Cruciani M, Gatti G, Lazzarini L et al (1996) Penetration of vancomycin into human lung tissue. J Antimicrob Chemother 38(5):865-869
148. Kollef MH, Rello J, Cammarata SK, Croos-Dabrera RV, Wunderink RG (2004) Clinical cure and survival in Gram-positive ventilator-associated pneumonia: retrospective analysis of two double-blind studies comparing linezolid with vancomycin. Intensive Care Med 30(3):388-394
149. Wunderink RG, Rello J, Cammarata SK, Croos-Dabrera RV, Kollef MH (2003) Linezolid vs vancomycin: analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia. Chest 124(5):1789-1797
150. Sharpe JN, Shively EH, Polk HC Jr (2005) Clinical and economic outcomes of oral linezolid versus intravenous vancomycin in the treatment of MRSA-complicated, lower-extremity skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus. Am J Surg 189(4):425-428
151. Weigelt J, Itani K, Stevens D, Lau W, Dryden M, Knirsch C (2005) Linezolid versus vancomycin in treatment of complicated skin and soft tissue infections. Antimicrob Agents Chemother 49(6):2260-2266
152. Weigelt J, Kaafarani HM, Itani KM, Swanson RN (2004) Linezolid eradicates MRSA better than vancomycin from surgical-site infections. Am J Surg 188(6):760-766
153. Gang RK, Sanyal SC, Mokaddas E, Lari AR (1999) Rifampicin as an adjunct to vancomycin therapy in MRSA septicaemia in burns. Burns 25(7):640-644
154. Grif K, Dierich MP, Pfaller K, Miglioli PA, Allerberger F (2001) In vitro activity of fosfomycin in combination with various antistaphylococcal substances. J Antimicrob Chemother 48(2):209-217
155. Yzerman EP, Boelens HA, Vogel M, Verbrugh HA (1998) Efficacy and safety of teicoplanin plus rifampicin in the treatment of bacteraemic infections caused by Staphylococcus aureus. J Antimicrob Chemother 42(2):233-239
156. Howden BP, Ward PB, Charles PG et al (2004) Treatment outcomes for serious infections caused by methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility. Clin Infect Dis 38(4):521-528
157. Baddour LM, Yu VL, Klugman KP et al (2004) Combination antibiotic therapy lowers mortality among severely ill patients with pneumococcal bacteremia. Am J Respir Crit Care Med 170(4):440-444
158. Nguyen MH, Peacock JE Jr, Tanner DC et al (1995) Therapeutic approaches in patients with candidemia. Evaluation in a multicenter, prospective, observational study. Arch Intern Med 155(22):2429-2435
159. Jacobs S, Price Evans DA, Tariq M, Al Omar NF (2003) Fluconazole improves survival in septic shock: a randomized double-blind prospective study. Crit Care Med 31(7):1938-1946
160. Bochud PY, Glauser MP, Calandra T (2001) Antibiotics in sepsis. Intensive Care Med 27(Suppl 1):S33-S48
161. Sobel JD, Rex JH (2001) Invasive candidiasis: turning risk into a practical prevention policy? Clin Infect Dis 33(2):187-190
162. Link H, Bohme A, Cornely OA et al (2003) Antimicrobial therapy of unexplained fever in neutropenic patients-guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO), Study Group Interventional Therapy of Unexplained Fever, Arbeitsgemeinschaft Supportivmaßnahmen in der Onkologie (ASO) of the Deutsche Krebsgesellschaft (DKG-German Cancer Society). Ann Hematol 82(Suppl 2):S105-S117
163. Diagnostik und Therapie von Infektionen bei Patienten in der Hämatologie und Onkologie (2004) Leitlinien der Sektion Infektionen in der Hämatologie/Onkologie der Paul-Ehrlich-Gesellschaft e.V. Chemother J 13(3):134-141
164. Phillips P, Shafran S, Garber G et al (1997) Multicenter randomized trial of fluconazole versus amphotericin B for treatment of candidemia in non-neutropenic patients. Canadian Candidemia Study Group. Eur J Clin Microbiol Infect Dis 16(5):337-345
165. Anaissie EJ, Vartivarian SE, Abi-Said D et al (1996) Fluconazole versus amphotericin B in the treatment of hematogenous candidiasis: a matched cohort study. Am J Med 101(2):170-176
166. Driessen M, Ellis JB, Cooper PA et al (1996) Fluconazole vs. amphotericin B for the treatment of neonatal fungal septicemia: a prospective randomized trial. Pediatr Infect Dis J 15(12):1107-1112
167. Rivers E, Nguyen B, Havstad S et al (2001) Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345(19):1368-1377
168. Swenson JD, Bull D, Stringham J (2001) Subjective assessment of left ventricular preload using transesophageal echocardiography: corresponding pulmonary artery occlusion pressures. J Cardiothorac Vasc Anesth 15(5):580-583
169. Buhre W, Buhre K, Kazmaier S, Sonntag H, Weyland A (2001) Assessment of cardiac preload by indicator dilution and transoesophageal echocardiography. Eur J Anaesthesiol 18(10):662-667
170. Kumar A, Anel R, Bunnell E et al (2004) Pulmonary artery occlusion pressure and central venous pressure fail to predict ventricular filling volume, cardiac performance, or the response to volume infusion in normal subjects. Crit Care Med 32(3):691-699
171. Godje O, Peyerl M, Seebauer T, Lamm P, Mair H, Reichart B (1998) Central venous pressure, pulmonary capillary wedge pressure and intrathoracic blood volumes as preload indicators in cardiac surgery patients. Eur J Cardiothorac Surg 13(5):533-539, discussion 9-40
172. Finfer S, Bellomo R, Boyce N, French J, Myburgh J, Norton R (2004) A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 350(22):2247-2256
173. Schierhout G, Roberts I (1998) Fluid resuscitation with colloid or crystalloid solutions in critically ill patients: a systematic review of randomised trials. BMJ 316(7136):961-964
174. Alderson P, Bunn F, Lefebvre C et al (2002) Human albumin solution for resuscitation and volume expansion in critically ill patients. Cochrane Database Syst Rev (1):CD001208
175. Meier-Hellmann A (2000) Hämodynamische Stabilisierung in der Sepsis. Anästhesiologie & Intensivmedizin 41:601-613
176. 2 Collaborative Group. N Engl J Med 333(16):1025-1032
177. Kern JW, Shoemaker WC (2002) Meta-analysis of hemodynamic optimization in high-risk patients. Crit Care Med 30(8):1686-1692
178. Hayes MA, Yau EH, Timmins AC, Hinds CJ, Watson D (1993) Response of critically ill patients to treatment aimed at achieving supranormal oxygen delivery and consumption. Relationship to outcome. Chest 103:886-895
179. Mullner M, Urbanek B, Havel C, Losert H, Waechter F, Gamper G (2004) Vasopressors for shock. Cochrane Database Syst Rev (3):CD003709
180. Martin C, Viviand X, Leone M, Thirion X (2000) Effect of norepinephrine on the outcome of septic shock. Crit Care Med 28(8):2758-2765
181. Levy B, Bollaert PE, Charpentier C et al (1997) Comparison of norepinephrine and dobutamine to epinephrine for hemodynamics, lactate metabolism, and gastric tonometric variables in septic shock: a prospective, randomized study. Intensive Care Med 23(3):282-287
182. Meier-Hellmann A, Reinhart K, Bredle DL, Specht M, Spies CD, Hannemann L (1997) Epinephrine impairs splanchnic perfusion in septic shock. Crit Care Med 25(3):399-404
183. Prielipp RC, MacGregor DA, Royster RL, Kon ND, Hines MH, Butterworth JFt (1998) Dobutamine antagonizes epinephrine's biochemical and cardiotonic effects: results of an in vitro model using human lymphocytes and a clinical study in patients recovering from cardiac surgery. Anesthesiology 89(1):49-57
184. Bellomo R, Chapman M, Finfer S, Hickling K, Myburgh J (2000) Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial. Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group. Lancet 356(9248):2139-2143
185. Marik PE, Iglesias J (1999) Low-dose dopamine does not prevent acute renal failure in patients with septic shock and oliguria. NORASEPT II Study Investigators. Am J Med 107(4):387-390
186. Chertow GM, Sayegh MH, Allgren RL, Lazarus JM (1996) Is the administration of dopamine associated with adverse or favorable outcomes in acute renal failure? Auriculin Anaritide Acute Renal Failure Study Group. Am J Med 101(1):49-53
187. Kellum JA, J MD (2001) Use of dopamine in acute renal failure: a meta-analysis. Crit Care Med 29(8):1526-1531
188. Marik PE (2002) Low-dose dopamine: a systematic review. Intensive Care Med 28(7):877-883
189. Debaveye YA, Van den Berghe GH (2004) Is there still a place for dopamine in the modern intensive care unit? Anesth Analg 98(2):461-468
190. Meier-Hellmann A, Bredle DL, Specht M, Hannemann L, Reinhart K (1999) Dopexamine increases splanchnic blood flow but decreases gastric mucosal pH in severe septic patients treated with dobutamine. Crit Care Med 27(10):2166-2171
191. Bennett ED (1998) Dopexamine: much more than a vasoactive agent. Crit Care Med 26(10):1621-1622
192. Byers RJ, Eddleston JM, Pearson RC, Bigley G, McMahon RF (1999) Dopexamine reduces the incidence of acute inflammation in the gut mucosa after abdominal surgery in high-risk patients. Crit Care Med 27(9):1787-1793
193. Kiefer P, Tugtekin I, Wiedeck H et al (2000) Effect of a dopexamine-induced increase in cardiac index on splanchnic hemodynamics in septic shock. Am J Respir Crit Care Med 161(3 Pt 1):775-779
194. Schmidt W, Hacker A, Gebhard MM, Martin E, Schmidt H (1998) Dopexamine attenuates endotoxin-induced microcirculatory changes in rat mesentery: role of beta2 adrenoceptors. Crit Care Med 26(10):1639-1645
195. Dunser MW, Mayr AJ, Ulmer H et al (2003) Arginine vasopressin in advanced vasodilatory shock: a prospective, randomized, controlled study. Circulation 107(18):2313-2319
196. Tsuneyoshi I, Yamada H, Kakihana Y, Nakamura M, Nakano Y, Boyle WA (2001) Hemodynamic and metabolic effects of low-dose vasopressin infusions in vasodilatory septic shock, 3rd. Crit Care Med 29(3):487-493
197. Malay MB, Ashton RC, Jr, Landry DW, Townsend RN (1999) Low-dose vasopressin in the treatment of vasodilatory septic shock. J Trauma 47(4):699-703, discussion-5
198. Patel BM, Chittock DR, Russell JA, Walley KR (2002) Beneficial effects of short-term vasopressin infusion during severe septic shock. Anesthesiology 96(3):576-582
199. Dunser MW, Mayr AJ, Tur A et al (2003) Ischemic skin lesions as a complication of continuous vasopressin infusion in catecholamine-resistant vasodilatory shock: incidence and risk factors. Crit Care Med 31(5):1394-1398
200. Mutlu GM, Factor P (2004) Role of vasopressin in the management of septic shock. Intensive Care Med 30(7):1276-1291
201. Hopkins RO, Weaver LK, Pope D, Orme JF, Bigler ED, Larson LV (1999) Neuropsychological sequelae and impaired health status in survivors of severe acute respiratory distress syndrome. Am J Respir Crit Care Med 160(1):50-56
202. Acute Respiratory Distress Syndrome Network (2000) Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 342(18):1301-1308
203. Amato MB, Barbas CS, Medeiros DM et al (1998) Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome. N Engl J Med 338(6):347-354
204. Bidani A, Tzouanakis AE, Cardenas VJ Jr, Zwischenberger JB (1994) Permissive hypercapnia in acute respiratory failure. JAMA 272(12):957-962
205. Hickling KG, Walsh J, Henderson S, Jackson R (1994) Low mortality rate in adult respiratory distress syndrome using low-volume, pressure-limited ventilation with permissive hypercapnia: a prospective study. Crit Care Med 22(10):1568-1578
206. Martin GS, Bernard GR (2001) Airway and lung in sepsis. Intensive Care Med 27(Suppl 1):S63-S79
207. Gattinoni L, Tognoni G, Pesenti A et al (2001) Effect of prone positioning on the survival of patients with acute respiratory failure. N Engl J Med 345(8):568-573
208. Guerin C, Gaillard S, Lemasson S et al (2004) Effects of systematic prone positioning in hypoxemic acute respiratory failure: a randomized controlled trial. JAMA 292(19):2379-2387
209. Lundin S, Mang H, Smithies M, Stenqvist O, Frostell C (1999) Inhalation of nitric oxide in acute lung injury: results of a European multicentre study. The European Study Group of Inhaled Nitric Oxide. Intensive Care Med 25(9):911-919
210. Taylor RW, Zimmerman JL, Dellinger RP et al (2004) Low-dose inhaled nitric oxide in patients with acute lung injury: a randomized controlled trial. JAMA 291(13):1603-1609
211. Sokol J, Jacobs SE, Bohn D (2003) Inhaled nitric oxide for acute hypoxic respiratory failure in children and adults: a meta-analysis. Anesth Analg 97(4):989-998
212. Esteban A, Alia I, Gordo F et al (1997) Extubation outcome after spontaneous breathing trials with T-tube or pressure support ventilation. The Spanish Lung Failure Collaborative Group. Am J Respir Crit Care Med 156(2 Pt 1):459-465
213. Esteban A, Alia I, Tobin MJ et al (1999) Effect of spontaneous breathing trial duration on outcome of attempts to discontinue mechanical ventilation. Spanish Lung Failure Collaborative Group. Am J Respir Crit Care Med 159(2):512-518
214. Ely EW, Baker AM, Dunagan DP et al (1996) Effect on the duration of mechanical ventilation of identifying patients capable of breathing spontaneously. N Engl J Med 335(25):1864-1869
215. Ely EW, Bennett PA, Bowton DL, Murphy SM, Florance AM, Haponik EF (1999) Large scale implementation of a respiratory therapist-driven protocol for ventilator weaning. Am J Respir Crit Care Med 159(2):439-446
216. Bone RC, Fisher CJ Jr, Clemmer TP, Slotman GJ, Metz CA, Balk RA (1987) A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N Engl J Med 317 (11):653-658
217. The Veterans Administration Systemic Sepsis Cooperative Study Group (1987) Effect of high-dose glucocorticoid therapy on mortality in patients with clinical signs of systemic sepsis. N Engl J Med 317(11):659-665
218. Annane D, Sebille V, Charpentier C et al (2002) Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 288 (7):862-871
219. Marik PE, Zaloga GP (2003) Adrenal insufficiency during septic shock. Crit Care Med 31(1):141-145
220. Zaloga GP, Marik P (2001) Hypothalamic-pituitary-adrenal insufficiency. Crit Care Clin 17(1):25-41
221. Dunn JF, Nisula BC, Rodbard D (1981) Transport of steroid hormones: binding of 21 endogenous steroids to both testosterone-binding globulin and corticosteroid-binding globulin in human plasma. J Clin Endocrinol Metab 53(1):58-68
222. Beishuizen A, Thijs LG, Vermes I (2001) Patterns of corticosteroid- binding globulin and the free cortisol index during septic shock and multi-trauma. Intensive Care Med 27(10):1584-1591
223. Keh D, Boehnke T, Weber-Cartens S et al (2003) Immunologic and hemodynamic effects of "low-dose" hydrocortisone in septic shock: a double-blind, randomized, placebo-controlled, crossover study. Am J Respir Crit Care Med 167 (4):512-520
224. Bernard GR, Vincent JL, Laterre PF et al (2001) Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 344(10):699-709
225. Deans KJ, Minneci PC, Eichacker PQ, Natanson C (2004) The efficacy of drotrecogin alfa depends on severity of illness. Crit Care Med 32(11):2347
226. Angus DC, Laterre PF, Heiterbrand J et al (2004) The effect of drotrecogin alfa (activated) on long-term survival after severe sepsis. Crit Care Med 32(11):2199-2206
227. European Medicines Agency (2005) Committee for Medicinal Products for Human Use. Press Release EMEA/138444/. http://www.emea.eu.int/pdfs/human/press/ pr/12130705en.pdf
228. Warren BL, Eid A, Singer P et al (2001) Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial. JAMA 286(15):1869-1878
229. Pildal J, Gotzsche PC (2004) Polyclonal immunoglobulin for treatment of bacterial sepsis: a systematic review. Clin Infect Dis 39(1):38-46
230. Alejandria MM, Lansang MA, Dans LF, Mantaring JB (2000) Intravenous immunoglobulin for treating sepsis and septic shock. Cochrane Database Syst Rev (2):CD001090
231. Heyland DK, Dhaliwal R, Suchner U, Berger MM (2005) Antioxidant nutrients: a systematic review of trace elements and vitamins in the critically ill patient. Intensive Care Med 31(3):327-337
232. Haupt MT, Jastremski MS, Clemmer TP, Metz CA, Goris GB (1991) Effect of ibuprofen in patients with severe sepsis: a randomized, double-blind, multicenter study. The Ibuprofen Study Group. Crit Care Med 19(11):1339-1347
233. Arons MM, Wheeler AP, Bernard GR et al (1999) Effects of ibuprofen on the physiology and survival of hypothermic sepsis. Ibuprofen in Sepsis Study Group. Crit Care Med 27(4):699-707
234. Bernard GR, Wheeler AP, Russell JA et al (1997) The effects of ibuprofen on the physiology and survival of patients with sepsis. The Ibuprofen in Sepsis Study Group. N Engl J Med 336(13):912-918
235. Takala J, Ruokonen E, Webster NR et al (1999) Increased mortality associated with growth hormone treatment in critically ill adults. N Engl J Med 341(11):785-792
236. Holcroft JW, Vassar MJ, Weber CJ (1986) Prostaglandin E1 and survival in patients with the adult respiratory distress syndrome. A prospective trial. Ann Surg 203(4):371-378
237. Bone RC, Slotman G, Maunder R et al (1989) Randomized double-blind, multicenter study of prostaglandin E1 in patients with the adult respiratory distress syndrome. Prostaglandin E1 Study Group. Chest 96(1):114-119
238. Silverman HJ, Slotman G, Bone RC et al (1990) Effects of prostaglandin E1 on oxygen delivery and consumption in patients with the adult respiratory distress syndrome. Results from the prostaglandin E1 multicenter trial. The Prostaglandin E1 Study Group. Chest 98(2):405-410
239. Abraham E, Baughman R, Fletcher E et al (1999) Liposomal prostaglandin E1 (TLC C-53) in acute respiratory distress syndrome: a controlled, randomized, double-blind, multicenter clinical trial. TLC C-53 ARDS Study Group. Crit Care Med 27(8):1478-1485
240. Yang S, Zhou M, Koo DJ, Chaudry IH, Wang P (1999) Pentoxifylline prevents the transition from the hyperdynamic to hypodynamic response during sepsis. Am J Physiol 277(3 Pt 2):H1036-1044
241. Staubach KH, Schroder J, Stuber F, Gehrke K, Traumann E, Zabel P (1998) Effect of pentoxifylline in severe sepsis: results of a randomized, double-blind, placebo-controlled study. Arch Surg 133(1):94-100
242. Lauterbach R, Pawlik D, Kowalczyk D, Ksycinski W, Helwich E, Zembala M (1999) Effect of the immunomodulating agent, pentoxifylline, in the treatment of sepsis in prematurely delivered infants: a placebo-controlled, double-blind trial. Crit Care Med 27(4):807-814
243. Molnar Z, Shearer E, Lowe D (1999) N-Acetylcysteine treatment to prevent the progression of multisystem organ failure: a prospective, randomized, placebo-controlled study. Crit Care Med 27(6):1100-1104
244. Zhang P, Bagby GJ, Stoltz DA, Summer WR, Nelson S (1998) Enhancement of peritoneal leukocyte function by granulocyte colony-stimulating factor in rats with abdominal sepsis. Crit Care Med 26(2):315-321
245. Lundblad R, Nesland JM, Giercksky KE (1996) Granulocyte colony-stimulating factor improves survival rate and reduces concentrations of bacteria, endotoxin, tumor necrosis factor, and endothelin-1 in fulminant intraabdominal sepsis in rats. Crit Care Med 24(5):820-826
246. Karzai W, von Specht BU, Parent C et al (1999) G-CSF during Escherichia coli versus Staphylococcus aureus pneumonia in rats has fundamentally different and opposite effects. Am J Respir Crit Care Med 159(5 Pt 1):1377-1382
247. Heard SO, Fink MP, Gamelli RL et al (1998) Effect of prophylactic administration of recombinant human granulocyte colony-stimulating factor (filgrastim) on the frequency of nosocomial infections in patients with acute traumatic brain injury or cerebral hemorrhage. The Filgrastim Study Group. Crit Care Med 26(4):748-754
248. Root RK, Lodato RF, Patrick W et al (2003) Multicenter, double-blind, placebo-controlled study of the use of filgrastim in patients hospitalized with pneumonia and severe sepsis. Crit Care Med 31(2):367-373
249. Bellomo R, Ronco C (1999) Continuous renal replacement therapy in the intensive care unit. Intensive Care Med 25(8):781-789
250. Silvester W (1998) Outcome studies of continuous renal replacement therapy in the intensive care unit. Kidney Int Suppl 66:5138-5141
251. Journois D (1999) Hemofiltration during cardiopulmonary bypass. Minerva Anestesiol 65(6):427-432
252. Reeves JH, Butt WW, Shann F et al (1999) Continuous plasmafiltration in sepsis syndrome. Plasmafiltration in Sepsis Study Group. Crit Care Med 27(10):2096-2104
253. Churchwell KB, McManus ML, Kent P et al (1995) Intensive blood and plasma exchange for treatment of coagulopathy in meningococcemia. J Clin Apheresis 10(4):171-177
254. Cade JF (1982) High risk of the critically ill for venous thromboembolism. Crit Care Med 10(7):448-450
255. Belch JJ, Lowe GD, Ward AG, Forbes CD, Prentice CR (1981) Prevention of deep vein thrombosis in medical patients by low-dose heparin. Scott Med J 26(2):115-117
256. Samama MM, Cohen AT, Darmon JY et al (1999) A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group. N Engl J Med 341(11):793-800
257. Pérez J, Dellinger RP (2001) Other supportive therapies in sepsis. Intensive Care Med 27(Suppl 1):S116-S127
258. Cestac P, Bagheri H, Lapeyre-Mestre M et al (2003) Utilisation and safety of low molecular weight heparins: prospective observational study in medical inpatients. Drug Saf 26(3):197-207
259. Barr J, Hecht M, Flavin KE, Khorana A, Gould MK (2004) Outcomes in critically ill patients before and after the implementation of an evidence-based nutritional management protocol. Chest 125(4):1446-1457
260. Martin CM, Doig GS, Heyland DK, Morrison T, Sibbald WJ (2004) Multicentre, cluster-randomized clinical trial of algorithms for critical-care enteral and parenteral therapy (ACCEPT). Cmaj 170(2):197-204
261. Ibrahim EH, Mehringer L, Prentice D et al (2002) Early versus late enteral feeding of mechanically ventilated patients: results of a clinical trial. JPEN J Parenter Enteral Nutr 26(3):174-181
262. Kearns PJ, Chin D, Mueller L, Wallace K, Jensen WA, Kirsch CM (2000) The incidence of ventilator-associated pneumonia and success in nutrient delivery with gastric versus small intestinal feeding: a randomized clinical trial. Crit Care Med 28(6):1742-1746
263. Gramlich L, Kichian K, Pinilla J, Rodych NJ, Dhaliwal R, Heyland DK (2004) Does enteral nutrition compared to parenteral nutrition result in better outcomes in critically ill adult patients? A systematic review of the literature. Nutrition 20(10):843-848
264. Simpson F, Doig GS (2005) Parenteral vs. enteral nutrition in the critically ill patient: a meta-analysis of trials using the intention to treat principle. Intensive Care Med 31(1):12-23
265. Braunschweig CL, Levy P, Sheean PM, Wang X (2001) Enteral compared with parenteral nutrition: a meta-analysis. Am J Clin Nutr 74(4):534-542
266. Gadek JE, DeMichele SJ, Karlstad MD et al (1999) Effect of enteral feeding with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants in patients with acute respiratory distress syndrome. Enteral Nutrition in ARDS Study Group. Crit Care Med 27(8):1409-1420
267. Galban C, Montejo JC, Mesejo A et al (2000) An immune-enhancing enteral diet reduces mortality rate and episodes of bacteremia in septic intensive care unit patients. Crit Care Med 28(3):643-648
268. Bertolini G, Iapichino G, Radrizzani D et al (2003) Early enteral immunonutrition in patients with severe sepsis: results of an interim analysis of a randomized multicentre clinical trial. Intensive Care Med 29(5):834-840
269. Bower RH, Cerra FB, Bershadsky B et al (1995) Early enteral administration of a formula (Impact) supplemented with arginine, nucleotides, and fish oil in intensive care unit patients: results of a multicenter, prospective, randomized, clinical trial. Crit Care Med 23(3):436-449
270. Stoner HB, Little RA, Frayn KN, Elebute AE, Tresadern J, Gross E (1983) The effect of sepsis on the oxidation of carbohydrate and fat. Br J Surg 70(1):32-35
271. Battistella FD, Widergren JT, Anderson JT, Siepler JK, Weber JC, MacColl K (1997) A prospective, randomized trial of intravenous fat emulsion administration in trauma victims requiring total parenteral nutrition. J Trauma 43(1):52-8, discussion 8-60
272. Goeters C, Wenn A, Mertes N et al (2002) Parenteral L-alanyl-L-glutamine improves 6-month outcome in critically ill patients. Crit Care Med 30(9):2032-2037
273. Griffiths RD, Allen KD, Andrews FJ, Jones C (2002) Infection, multiple organ failure, and survival in the intensive care unit: influence of glutamine-supplemented parenteral nutrition on acquired infection. Nutrition 18(7-8):546-552
274. Griffiths RD, Jones C, Palmer TE (1997) Six-month outcome of critically ill patients given glutamine-supplemented parenteral nutrition. Nutrition 13(4):295-302
275. Powell-Tuck J, Jamieson CP, Bettany GE et al (1999) A double blind, randomised, controlled trial of glutamine supplementation in parenteral nutrition. Gut 45 (1):82-88
276. Schloerb PR, Amare M (1993) Total parenteral nutrition with glutamine in bone marrow transplantation and other clinical applications (a randomized, double-blind study). JPEN J Parenter Enteral Nutr 17(5):407-413
277. Wischmeyer PE, Lynch J, Liedel J et al (2001) Glutamine administration reduces Gram-negative bacteremia in severely burned patients: a prospective, randomized, double-blind trial versus isonitrogenous control. Crit Care Med 29(11):2075-2080
278. Ziegler TR, Young LS, Benfell K et al (1992) Clinical and metabolic efficacy of glutamine-supplemented parenteral nutrition after bone marrow transplantation. A randomized, double-blind, controlled study. Ann Intern Med 116(10):821-828
279. Heyland DK, Dhaliwal R, Drover JW, Gramlich L, Dodek P (2003) Canadian clinical practice guidelines for nutrition support in mechanically ventilated, critically ill adult patients. JPEN J Parenter Enteral Nutr 27(5):355-373
280. Borrero E, Bank S, Margolis I, Schulman ND, Chardavoyne R (1985) Comparison of antacid and sucralfate in the prevention of gastrointestinal bleeding in patients who are critically ill. Am J Med 79(2C):62-64
281. Bresalier RS, Grendell JH, Cello JP, Meyer AA (1987) Sucralfate suspension versus titrated antacid for the prevention of acute stress-related gastrointestinal hemorrhage in critically ill patients. Am J Med 83(3B):110-116
282. Cook D, Guyatt G, Marshall J et al (1998) A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. Canadian Critical Care Trials Group. N Engl J Med 338(12):791-797
283. Stothert JC Jr, Simonowitz DA, Dellinger EP et al (1980) Randomized prospective evaluation of cimetidine and antacid control of gastric pH in the critically ill. Ann Surg 192(2):169-174
284. MacLaren R, Jarvis CL, Fish DN (2001) Use of enteral nutrition for stress ulcer prophylaxis. Ann Pharmacother 35(12):1614-1623
285. Cooper DJ, Walley KR, Wiggs BR, Russell JA (1990) Bicarbonate does not improve hemodynamics in critically ill patients who have lactic acidosis. A prospective, controlled clinical study. Ann Intern Med 112(7):492-498
286. Mathieu D, Neviere R, Billard V, Fleyfel M, Wattel F (1991) Effects of bicarbonate therapy on hemodynamics and tissue oxygenation in patients with lactic acidosis: a prospective, controlled clinical study. Crit Care Med 19(11):1352-1356
287. Kellum JA, Angus DC, Johnson JP et al (2002) Continuous versus intermittent renal replacement therapy: a meta-analysis. Intensive Care Med 28(1):29-37
288. Mehta RL, McDonald B, Gabbai FB et al (2001) A randomized clinical trial of continuous versus intermittent dialysis for acute renal failure. Kidney Int 60(3):1154-1163
289. Hébert PC, Wells G, Blajchman MA et al (1999) A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 340(6):409-417
290. Marik PE, Sibbald WJ (1993) Effect of stored-blood transfusion on oxygen delivery in patients with sepsis. Journal of the American Medical Association 269:3024-3029
291. Lorente JA, Landin L, De Pablo R, Renes E, Rodriguez-Diaz R, Liste D (1993) Effects of blood transfusion on oxygen transport variables in severe sepsis. Crit Care Med 21(9):1312-1318
292. Corwin HL, Gettinger A, Rodriguez RM et al (1999) Efficacy of recombinant human erythropoietin in the critically ill patient: a randomized, double-blind, placebo-controlled trial. Crit Care Med 27(11):2346-2350
293. Corwin HL, Gettinger A, Pearl RG et al (2002) Efficacy of recombinant human erythropoietin in critically ill patients: a randomized controlled trial. Jama 288(22):2827-2835
294. Vorstand und Wissenschaftlicher Beirat der Bundesärztekammer (2003) Leitlinien zur Therapie mit Blutkomponenten und Plasmaderivaten Deutscher Ärzte-Verlag, Köln
295. Kress JP, Pohlman AS, O'Connor MF, Hall JB (2000) Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation. N Engl J Med 342(20):1471-1477
296. Rossiter A, Souney PF, McGowan S, Carvajal P (1991) Pancuronium-induced prolonged neuromuscular blockade. Crit Care Med 19(12):1583-1587
297. Partridge BL, Abrams JH, Bazemore C, Rubin R (1990) Prolonged neuromuscular blockade after long-term infusion of vecuronium bromide in the intensive care unit. Crit Care Med 18(10):1177-1179
298. Vanderheyden BA, Reynolds HN, Gerold KB, Emanuele T (1992) Prolonged paralysis after long-term vecuronium infusion. Crit Care Med 20(2):304-307
299. Meyer KC, Prielipp RC, Grossman JE, Coursin DB (1994) Prolonged weakness after infusion of atracurium in two intensive care unit patients. Anesth Analg 78(4):772-774
300. Manthous CA, Chatila W (1994) Prolonged weakness after the withdrawal of atracurium. Am J Respir Crit Care Med 150(5 Pt 1):1441-1443
301. Prielipp RC, Coursin DB, Scuderi PE et al (1995) Comparison of the infusion requirements and recovery profiles of vecuronium and cisatracurium 51W89 in intensive care unit patients. Anesth Analg 81(1):3-12